# A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

> clinical trial · VERIFIED · 2026-07-20

Status: NOT_YET_RECRUITING · Sponsor: Kure Cells, INC · Condition: Lymphoma Nonhodgkin

- Company: Kure Cells, INC
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07713459

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.